Dr. Emma Allister
The John P. Robarts Research Institute
Dr. Emma Allister is examining liver-derived lipoproteins - particles that help transport cholesterol and lipids throughout the body - and factors regulating their production. Increased production of lipoproteins by the liver is associated with higher blood lipid levels and an increased risk of cardiovascular disease. Dr. Allister hopes to gain insight on how lipoproteins are assembled in the liver, and she will explore ways to lower their concentration in the blood. In her study, she will investigate the use of naringenin, a citrus flavonoid shown to lower lipoprotein levels in animal models, to help regulate lipoprotein metabolism. This would benefit patients with high lipid levels by decreasing their risk of heart disease and stroke.
Dr. Allister completed her PhD at Curtin University in Western Australia, where she investigated insulin's effect on the production of intestinal lipoproteins. She is now studying at the John P. Robarts Research Institute in London, Ontario, under the supervision of Dr. Murray Huff.
The Heart and Stroke Foundation of Canada and AstraZeneca Canada Inc. are proud to support work like Dr. Allister's, which will aid in the prevention and treatment of cardiovascular disease. Upon completing her research fellowship, Dr. Allister plans to continue in the field of cardiovascular/ diabetes research.
Supported by AstraZeneca Canada Inc.